Assenagon Asset Management
IMNN icon

Assenagon Asset Management’s Imunon IMNN Stock Holding History

Assenagon Asset Management’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-105
Closed -$11K – 1488
2021
Q4 		$11K Buy
+105
New +$16.4K ﹤0.01% 1409

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Assenagon Asset Management's IMNN Position: Q1 2022 in Review

Assenagon Asset Management sold out of Imunon (IMNN) in Q1 2022, closing a stake of 105 shares — an estimated $11K sold.

Assenagon Asset Management first reported a position in IMNN in Q4 2021 and held it in 1 quarter. The position peaked at $11K in Q4 2021. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

  • Assenagon Asset Management reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 105 Imunon shares in Q1 2022, an estimated $11K.
  • Assenagon Asset Management first reported a position in Imunon in Q4 2021 and held it in 1 quarter.
  • Assenagon Asset Management's Imunon position peaked at $11K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on Assenagon Asset Management's 13F filing for Q1 2022, filed 25 Apr 2022.